US3703591A - Triglyceride hydrolysis and assay - Google Patents
Triglyceride hydrolysis and assay Download PDFInfo
- Publication number
- US3703591A US3703591A US98904A US3703591DA US3703591A US 3703591 A US3703591 A US 3703591A US 98904 A US98904 A US 98904A US 3703591D A US3703591D A US 3703591DA US 3703591 A US3703591 A US 3703591A
- Authority
- US
- United States
- Prior art keywords
- glycerol
- lipase
- accordance
- pyruvate
- nadh
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000003556 assay Methods 0.000 title abstract description 16
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 title abstract description 13
- 230000007062 hydrolysis Effects 0.000 title description 8
- 238000006460 hydrolysis reaction Methods 0.000 title description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical class OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract description 93
- 238000000034 method Methods 0.000 abstract description 46
- 108090001060 Lipase Proteins 0.000 abstract description 32
- 239000004367 Lipase Substances 0.000 abstract description 32
- 102000004882 Lipase Human genes 0.000 abstract description 32
- 235000019421 lipase Nutrition 0.000 abstract description 32
- 239000004365 Protease Substances 0.000 abstract description 29
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 abstract description 26
- 108091005804 Peptidases Proteins 0.000 abstract description 25
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 abstract description 25
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract description 23
- 238000006243 chemical reaction Methods 0.000 abstract description 19
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 abstract description 13
- 230000003287 optical effect Effects 0.000 abstract description 11
- 102000057621 Glycerol kinases Human genes 0.000 abstract description 10
- 108700016170 Glycerol kinases Proteins 0.000 abstract description 10
- AWUCVROLDVIAJX-UHFFFAOYSA-N glycerol 1-phosphate Chemical compound OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 abstract description 10
- DTBNBXWJWCWCIK-UHFFFAOYSA-N phosphoenolpyruvic acid Chemical compound OC(=O)C(=C)OP(O)(O)=O DTBNBXWJWCWCIK-UHFFFAOYSA-N 0.000 abstract description 10
- 210000002966 serum Anatomy 0.000 abstract description 10
- 102000003855 L-lactate dehydrogenase Human genes 0.000 abstract description 9
- 108700023483 L-lactate dehydrogenases Proteins 0.000 abstract description 9
- 102000013009 Pyruvate Kinase Human genes 0.000 abstract description 8
- 108020005115 Pyruvate Kinase Proteins 0.000 abstract description 8
- 239000012736 aqueous medium Substances 0.000 abstract description 8
- 229930029653 phosphoenolpyruvate Natural products 0.000 abstract description 8
- 230000002255 enzymatic effect Effects 0.000 abstract description 7
- 230000007071 enzymatic hydrolysis Effects 0.000 abstract description 4
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 abstract description 4
- 238000005259 measurement Methods 0.000 abstract description 3
- 235000021243 milk fat Nutrition 0.000 abstract description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 abstract 1
- 230000008569 process Effects 0.000 description 28
- 235000019419 proteases Nutrition 0.000 description 22
- -1 lactate ion Chemical class 0.000 description 18
- 239000000203 mixture Substances 0.000 description 17
- 239000007788 liquid Substances 0.000 description 16
- 235000014113 dietary fatty acids Nutrition 0.000 description 13
- 229930195729 fatty acid Natural products 0.000 description 13
- 239000000194 fatty acid Substances 0.000 description 13
- 229950006238 nadide Drugs 0.000 description 13
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 12
- GNGACRATGGDKBX-UHFFFAOYSA-N dihydroxyacetone phosphate Chemical compound OCC(=O)COP(O)(O)=O GNGACRATGGDKBX-UHFFFAOYSA-N 0.000 description 12
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 10
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 7
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 229940088598 enzyme Drugs 0.000 description 7
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 229960002376 chymotrypsin Drugs 0.000 description 6
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 6
- 125000003831 tetrazolyl group Chemical group 0.000 description 6
- 101000892220 Geobacillus thermodenitrificans (strain NG80-2) Long-chain-alcohol dehydrogenase 1 Proteins 0.000 description 5
- WVVOBOZHTQJXPB-UHFFFAOYSA-N N-anilino-N-nitronitramide Chemical compound [N+](=O)([O-])N(NC1=CC=CC=C1)[N+](=O)[O-] WVVOBOZHTQJXPB-UHFFFAOYSA-N 0.000 description 5
- 239000007795 chemical reaction product Substances 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- 108090000317 Chymotrypsin Proteins 0.000 description 4
- 102000000587 Glycerolphosphate Dehydrogenase Human genes 0.000 description 4
- 108010041921 Glycerolphosphate Dehydrogenase Proteins 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 150000002431 hydrogen Chemical class 0.000 description 4
- 108010079522 solysime Proteins 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- RXGJTUSBYWCRBK-UHFFFAOYSA-M 5-methylphenazinium methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC=C2[N+](C)=C(C=CC=C3)C3=NC2=C1 RXGJTUSBYWCRBK-UHFFFAOYSA-M 0.000 description 3
- 108010004032 Bromelains Proteins 0.000 description 3
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 3
- 108010067372 Pancreatic elastase Proteins 0.000 description 3
- 102000016387 Pancreatic elastase Human genes 0.000 description 3
- 108090000526 Papain Proteins 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 241000303962 Rhizopus delemar Species 0.000 description 3
- 241000187392 Streptomyces griseus Species 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- 102000004142 Trypsin Human genes 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 229940120503 dihydroxyacetone Drugs 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 150000004665 fatty acids Chemical group 0.000 description 3
- 229910001425 magnesium ion Inorganic materials 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 229940055729 papain Drugs 0.000 description 3
- 235000019834 papain Nutrition 0.000 description 3
- 150000003626 triacylglycerols Chemical class 0.000 description 3
- 239000012588 trypsin Substances 0.000 description 3
- 241000588915 Klebsiella aerogenes Species 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229940092559 enterobacter aerogenes Drugs 0.000 description 2
- 150000002314 glycerols Chemical class 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000007306 turnover Effects 0.000 description 2
- CFYIUBWVKZQDOG-UHFFFAOYSA-N 4-[[2-[[2-[[1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]amino]-2-oxoethyl]amino]-4-oxobutanoic acid Chemical group C=1C=C([N+]([O-])=O)C=CC=1NC(=O)C(NC(=O)CNC(=O)CNC(=O)CCC(=O)O)CC1=CC=CC=C1 CFYIUBWVKZQDOG-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241000146387 Chromobacterium viscosum Species 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000006746 NADH Dehydrogenase Human genes 0.000 description 1
- 108010086428 NADH Dehydrogenase Proteins 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 108010059712 Pronase Proteins 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- BAECOWNUKCLBPZ-HIUWNOOHSA-N Triolein Natural products O([C@H](OCC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCC/C=C\CCCCCCCC)C(=O)CCCCCCC/C=C\CCCCCCCC BAECOWNUKCLBPZ-HIUWNOOHSA-N 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- TTWYZDPBDWHJOR-IDIVVRGQSA-L adenosine triphosphate disodium Chemical compound [Na+].[Na+].C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O TTWYZDPBDWHJOR-IDIVVRGQSA-L 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000012084 conversion product Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- SBBWEQLNKVHYCX-JTQLQIEISA-N ethyl L-tyrosinate Chemical group CCOC(=O)[C@@H](N)CC1=CC=C(O)C=C1 SBBWEQLNKVHYCX-JTQLQIEISA-N 0.000 description 1
- SKAWDTAMLOJQNK-LBPRGKRZSA-N ethyl N-acetyl-L-tyrosinate Chemical compound CCOC(=O)[C@@H](NC(C)=O)CC1=CC=C(O)C=C1 SKAWDTAMLOJQNK-LBPRGKRZSA-N 0.000 description 1
- 229960004279 formaldehyde Drugs 0.000 description 1
- 235000019256 formaldehyde Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 229960001983 magnesium aspartate Drugs 0.000 description 1
- RXMQCXCANMAVIO-CEOVSRFSSA-L magnesium;(2s)-2-amino-4-hydroxy-4-oxobutanoate Chemical compound [H+].[H+].[Mg+2].[O-]C(=O)[C@@H](N)CC([O-])=O.[O-]C(=O)[C@@H](N)CC([O-])=O RXMQCXCANMAVIO-CEOVSRFSSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 239000008057 potassium phosphate buffer Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 229940117972 triolein Drugs 0.000 description 1
- 229960004441 tyrosine Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/61—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving triglycerides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/02—Food
- G01N33/04—Dairy products
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/886—Streptomyces
- Y10S435/897—Streptomyces griseus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/911—Microorganisms using fungi
- Y10S435/939—Rhizopus
Definitions
- a number of alternative enzymatic procedures are provided for the glycerol assay, all in the original aqueous medium, such as conversion to glycerol-l-phosphate with glycerol kinase; conversion of ATP to ADP by the same reaction followed by conversion of the ADP plus phosphoenolpyruvate using pyruvate kinase to ATP and pyruvate ion followed by determining the latter; and alternatively con verting the pyruvate ion so formed with NAD-H using lactate dehydrogenase to lactate ion and NAD and determining the latter by optical measurement.
- This invention relates to a rapid method of determining fatty acid glycerol esters in various aqueous media, such as serum, milk, and the like.
- An object of the present invention is to provide a rapid and accurate procedure which liberates glycerol from its esterified form as a fatty acid ester, for example when present in aqueous media such as serum, and which permits the glycerol to be assayed by a variety of alternative methods without the necessity of isolating the glycerol from the medium under test.
- a lipase which may be of plant or animal origin, but among which we prefer and find best a microbial lipase, such as the lipase from Chromobacterium viscosum, variant paralipolyticum, crude or purified, the lipase from Rhizopus delemar, purified, for example as noted in Fukumoto et al., J. Gen. Appl. Microbiol., 10, 257-265 (1964); and lipases having similar activity; and second, a protease.
- a lipase which may be of plant or animal origin, but among which we prefer and find best a microbial lipase, such as the lipase from Chromobacterium viscosum, variant paralipolyticum, crude or purified, the lipase from Rhizopus delemar, purified, for example as noted in Fukumoto et al., J. Gen. Appl. Microbiol., 10, 257-265 (1964); and lipases having similar activity; and second
- Proteases in general maybe used, such as by way of example and not by limitation, chymotrypsin, trypsin, Streptomyces griseus protease (commercially available under the registered trademark Pronase), elastase, papain, and bromelin. Mixtures of these may also be employed. This simple enzyme mixture is in general sufficient, although the hydrolysis may generally be expedited somewhat by the simultaneous inclusion of a simple protein such as serum albumin, egg albumin, globulins, and the like.
- the glycerol liberated by the action of the enzyme mixture just described may be assayed in a number of ways, although we prefer one in particular which will now be described.
- a useful and preferred embodiment of our invention comprises an assay mixture containing the preferred constituents to carry out a single triglyceride assay in accordance with the invention.
- the preferred procedure involves the enzymatic hydrolysis as already described using the enzyme combination disclOsed, followed by the conversion of the liberated glycerol as likewise described
- Vial A may contain all the components needed for the assay except the glycerol kinase.
- the latter may be placed in Vial B.
- other distributions of the components are possible, any of those involved solely with glycerol conversion and subsequent steps being includable in Vial B if desired.
- Bovine serum albumin 5.0 mg.
- u-Chymotrypsin 1100 NLF. units Lipase, Rlzizopus delemar: 1200 lipase units (Total volume: 3 ml.)
- One (1) lipase unit is the quantity of enzyme which will release fatty acids from a substrate of triolein to require 1 ml. of 0.05 N potassium hydroxide for neutrali zation after a 30-min. incubation period at 37 C.
- N.F. unit of tar-chymotrypsin is that quantity of enzyme which will produce an absorbance change of 0.0075/minute at 237 nanometers when incubated with a substrate of N-acetyl-L-tyrosine ethyl ester under the conditions of assay.
- Vial B Glycerol 'kinase 2 I.U. (International Units)
- the assay in accordance with the invention is carried out by adding an aliquot of liquid containing the triglyceride to be assayed, which may be for example 50 #1. of serum, to the 3 ml. contents of Vial A. This is then incubated at between 25 C. and 37 C. for approximately ten minutes. The optical density is then determined at 340 nm. Then the 2 I.U. of glycerol kinase contained in Vial B is added, and the mixture allowed to stand for an additional minutes at the same temperature, whereupon the optical density is determined again. The difference is proportional to the triglyceride content of the aliquot.
- the essential contents of the reaction mixture in accordance with the invention comprises a microbial lipase; a protease; pyruvate kinase; lactate dehydrogenase; NADH; ATP; Phosphoenol pyruvate; a magnesium ion source; a buffer; and glycerol kinase.
- An alternative procedure consists in omitting the NADH and the lactate dehydrogenase from the mixture described above, so that only the first three reaction steps depicted hereinabove occur; and adding a sufiicient quantity of dinitrophenyl hydrazine to react with the pyruvate ion formed in the aforementioned third reaction step.
- the reaction product is colored when alkalized, and may be readily measured by a colorimeter.
- a further alternative procedure is to omit the phosphoenol pyruvate; the pyruvate kinase; and the lactate dehydrogenase from the reaction mixture previously described, and to add instead glycerol phosphate dehydrogenase, whereupon the a-glycerol phosphate and the NAD are converted respectively to dihydroxyacetone phosphate and NADH.
- the amount of NADH formed which is proportional to the amount of triglyceride originally present, can conveniently be measured by the increase in fluorescence.
- An alternative sub-procedure is to include also a sufficient quantity of dinitrophenyl hydrazine in this system as well which will result in the formation of a colored reaction product with the dihydroxyacetone phosphate liberated.
- the amount of the reaction product can then readily be determined with a colorimeter and is likewise a measure of the triglyceride originally present.
- a still further alternative procedure is to utilize a reaction mixture which provides only the enzymatic conversion to glycerol which is the first reaction step set forth in the tabulation hereinabove.
- the reaction mixture also includes NAD and glycerol dehydrogenase.
- NAD glycerol dehydrogenase
- the glycerol which is liberated in the first step is converted to dihydroxyacetone with the simultaneous production of NADH.
- the increase in optical density at 340 nm. then becomes a measure of the quantity of triglyceride originally present, as previously described.
- a suitable glycerol dehydrogenase is that obtainable from Enterobacter aerogenes; this enzyme is commercially available.
- An alternative subprocedure here is to add dinitrophenyl hydrazine, which forms a colored reaction product with the dihydroxy acetone, so that the latter may then be measured colorimetrically.
- the NADH which is quantitatively formed from the triglyceride may be caused to transfer its hydrogen (becoming oxidized in the process) to the tetrazolium salt, again quantitatively, through the mediation of any of several known substances, among which we prefer especially diaphorase or, alternatively, phenazine methosulfate.
- the amount of dye thus formed may be readily measured by colorimetry, i.e., by carrying out optical density change measurements in the visible region.
- the lipase unit has been defined hereinabove.
- the international unit of proteolytic activity is the amount of protease which causes a turnover of one micromol per minute of a substrate which is specific for the particular enzyme in question, under conditions approximating an optimum for the system considered.
- the substrate is tyrosine ethyl ester
- the turnover rate may be determined in any number of ways, as by the change in optical density at 237 nm., or by determining the amino acid liberated, as phenol reagent tyrosine equivalents or by formol titration.
- the N.F. (National Formulary) unit is occasionally used for proteases, and appears in an example hereinabove. Since 1 I.U. unit is equivalent to 28 NP. units, it will be seen that the 1100 NR units of chymotrypsin in the example is equal to 39 I.U. Since 1200 lipase units were present in the exemplary mixture, it will be seen that for each 1000 lipase units, our example shows about 32 LU. of protease.
- one of the vials e.g., Vial A
- the second vial e.g., Vial B
- the remaining components may be distributed as desired between the two vials.
- Our preferred distribution has been set forth hereinabove.
- the glycerol liberated is that quantity to be expected on the basis of complete hydrolysis of the triglycerides present, the latter being determined by standard procedures well known in the art.
- a-glycerol phosphate may also be named as glycerol-l-phoshpate; and that the fatty acid glycerol esters in serum may be and generally are referred to simply as triglycerides.
- one unit of lipase means the amount of lipase equivalent to one lipase unit as specified hereinabove.
- lipase is chosen from the class. consisting of Rhizopus delemar and Chromobacferium viscoswm lipases, and mixtures thereof.
- protease is chosen from the class consisting of chymotrypsin, trypsin, streptomyces griseus protease, elastase, papain, bromelin, and mixtures thereof.
- a process in accordance with claim 4 wherein from about 5 to about 500 LU. of said protease is present for each 1000 units of said lipase.
- a process in accordance with claim 2 wherein from about 5 to about 500 LU. of said protease is present for each 1000 units of said lipase.
- protease is chosen from the class consisting of chymotrypsin, trypsin, streptomyces griseus protease, elastase, papain, bromelin, and mixtures thereof.
- a process in accordance with claim 1 wherein, subsequent to said liberation of glycerol, adenosine triphosphate and glycerol kinase are added to said liquid in sufficient quantity to convert said glycerol to glycerol-l-phosphate and said adenosine triphosphate to adenosine diphosphate; and in which said adenosine diphosphate is assayed, whereby the original content of said fatty acid glycerol ester may be determined.
- a process in accordance with claim wherein to said aqueous liquid containing said glycerol-l-phosphate, nicotinamide adenine dinucleotide and glycerol phosphate dehydrogenase are added in sufficient quantity to convert said glycerol-l-phosphate and said NAD to dihydroxyacetone phosphate and nicotinamide adenine dinucleotide, reduced (NADH) respectively.
- said hydrogen transfer agent is selected from the class consisting of diaphorase and phenazine methosulfate.
- a process in accordance with claim 10 wherein to said aqueous liquid containing said glyceroll-phosphate in said ADP, there are added phosphoenol pyruvate and pyruvate kinase in sufficient quantity to convert said phosphoenol pyruvate to pyruvate ion, and in which said pyruvate ion is assayed to give an indication of the amount of said glycerol ester originally present.
- a process in accordance with claim 15 wherein to said aqueous liquid containing said pyruvate ion there are added NADH and lactate dehydrogenase in suflicient quantity to convert said pyruvate and said NADH to lactate ion and NAD respectively.
- a reagent combination for the analysis of fatty acid glycerol esters which comprises a first vial containing a lipase and a protease; a second vial containing glycerol kinase; and pyruvate kinase; lactate dehydrogenase; NADH; ATP; phosphoenol pyruvate; a magnesium ion source; and a buffer in any preselected distribution in said vials.
- a reagent combination in accordance with claim 28 wherein from about 5 to about 500 LU. of said protease is present for each 1000 units of said lipase.
Abstract
GLYCEROL ESTERS PRESENT IN AQUEOUS MEDIA, SUCH AS SERUM TRIGLYCERIDE AND MILK FAT, ARE ASSAYED BY COMPLETE ENZYMATIC HYDROLYSIS USING BOTH A LIPASE AND A PROTEASE, WHEREUPON THE LIBERATED GLYCEROL IS DETERMINED. A NUMBER OF ALTERNATIVE ENZYMATIC PROCEDURES ARE PROVIDED FOR THE GLYCEROL ASSAY, ALL IN THE ORGINAL AQUEOUS MEDIUM, SUCH AS CONVERSION TO GLYCEROL-1-PHOSPHATE WITH GLYCEROL KINASE; CONVERSION OF ATP TO ADP BY THE SAME RECTION FOLLOWED BY CONVERSION OF THE ADP PLUS PHOSPHOENOLPYRUVATE USING PYRUVATE KINASE TO ATP AND PYRUVATE ION FOLLOWED BY DETERMINING THE LATTER; AND ALTERNATIVELY CONVERTING THE PYRUVATE ION SO FORMED WITH NADH USING LACTATE DEHYDROGENASE TO LACTATE ION AND NAD AND DETERMINING THE LATTER BY OPTICAL MEASUREMENT.
Description
United States Patent 3,703,591 TRIGLYCERIDE HYDROLYSIS AND ASSAY Giovanni Bucolo, San Diego, and Harold David, Los glgsles, Calif., assignors to Calbiochem, Los Angeles,
1 N0 Drawing. Filed Dec. 16, 1970, Ser. No. 98,904 Int. Cl. ClZk 1/04 US. Cl. 195-103.5 R 35 Claims ABSTRACT OF THE DISCLOSURE Glycerol esters present in aqueous media, such as serum triglyceride and milk fat, are assayed by complete enzymatic hydrolysis using both a lipase and a protease, whereupon the liberated glycerol is determined. A number of alternative enzymatic procedures are provided for the glycerol assay, all in the original aqueous medium, such as conversion to glycerol-l-phosphate with glycerol kinase; conversion of ATP to ADP by the same reaction followed by conversion of the ADP plus phosphoenolpyruvate using pyruvate kinase to ATP and pyruvate ion followed by determining the latter; and alternatively con verting the pyruvate ion so formed with NAD-H using lactate dehydrogenase to lactate ion and NAD and determining the latter by optical measurement.
This invention relates to a rapid method of determining fatty acid glycerol esters in various aqueous media, such as serum, milk, and the like.
In many fields, but particularly in clinical biochemistry, it is important to determine the content of fatty acid esters of glycerol in a particular sample. The assay is of particular importance in human serum, where elevated levels are of great diagnostic value. Methods depending upon determination of the fatty acid moiety, and methods in which glycerol liberated from other sources contributes to' the total assay, have various disadvantages. A rapid, accurate method operating exclusively and at the same time completely on the fatty acid glycerol esters is an important desideratum in the clinical field, and prior art methods are in general not fully satisfactory.
An object of the present invention is to provide a rapid and accurate procedure which liberates glycerol from its esterified form as a fatty acid ester, for example when present in aqueous media such as serum, and which permits the glycerol to be assayed by a variety of alternative methods without the necessity of isolating the glycerol from the medium under test.
Other objects of the invention will appear as the description thereof proceeds.
Generally speaking, and in accordance with illustrative embodiments of our invention, we add to an aqueous medium containing the fatty acid glycerol to be assayed, a mixture of first a lipase, which may be of plant or animal origin, but among which we prefer and find best a microbial lipase, such as the lipase from Chromobacterium viscosum, variant paralipolyticum, crude or purified, the lipase from Rhizopus delemar, purified, for example as noted in Fukumoto et al., J. Gen. Appl. Microbiol., 10, 257-265 (1964); and lipases having similar activity; and second, a protease. Proteases in general maybe used, such as by way of example and not by limitation, chymotrypsin, trypsin, Streptomyces griseus protease (commercially available under the registered trademark Pronase), elastase, papain, and bromelin. Mixtures of these may also be employed. This simple enzyme mixture is in general sufficient, although the hydrolysis may generally be expedited somewhat by the simultaneous inclusion of a simple protein such as serum albumin, egg albumin, globulins, and the like.
As will be set forth in detail hereinbelow, the glycerol liberated by the action of the enzyme mixture just described may be assayed in a number of ways, although we prefer one in particular which will now be described.
We prefer to carry out the enzymatic hydrolysis of the triglycerides by the lipase-protease combination as just described in the presence of the components of three additional enzymatic transformation systems, whereby first, the glycerol which has been liberated is converted to a-glycerol phosphate by glycerol kinase with the simultaneous conversion of adenosine triphosphate to adenosine diphosphate; second, the conversion of the latter back to adenosine triphosphate with the simultaneous conversion of phosphoenolpyruvic acid to pyruvate ion under the action of pyruvate kinase; and third, the conversion of the pyruvate ion to lactate ion with the simultaneous conversion of nicotinamide adenine dinucleotide from its reduced to its oxidized form, under the action of lactate dehydrogenase. All of these system components are present simultaneously in the mixture, so that as the hydrolysis of the triglyceride proceeds, the optical density of the solution at 340 nanometers decreases as a result of the oxidation of the dinucleotide. This sequence of enzymatic conversions is indicated diagrammatically as follows:
enzymatic Trlgiycerldes---- GlyceroH- F. F.A.
hydrolysis LDH Pyruvate+NADH Lactate-l-NAD colored I.e., absorbs strongly at 340 nm.; molar extinction coefficient arr:6.22 X 10 2 I.e., transparent at 340 nm.
Abbreviations A useful and preferred embodiment of our invention comprises an assay mixture containing the preferred constituents to carry out a single triglyceride assay in accordance with the invention. Inasmuch as the preferred procedure involves the enzymatic hydrolysis as already described using the enzyme combination disclOsed, followed by the conversion of the liberated glycerol as likewise described, it is convenient to furnish the assay mixture in two separate containers, such as glass vials, one of which, which may be termed Vial A for convenience, may contain all the components needed for the assay except the glycerol kinase. The latter may be placed in Vial B. Of course, other distributions of the components are possible, any of those involved solely with glycerol conversion and subsequent steps being includable in Vial B if desired. However, we prefer and find best the following reaction mixture:
Vial A Potassium phosphate buffer, 0.1 M, pH 7 Magnesium aspartate: 1.6 mg.
ATP disodium: 0.9 M
Phosphoenol pyruvate: 0.9 M
Bovine serum albumin: 5.0 mg.
NADH to a final absorbance of 0.8 (optical density at LDH: 2 LU.
Pyruvate kinase: 6 I.U.
u-Chymotrypsin: 1100 NLF. units Lipase, Rlzizopus delemar: 1200 lipase units (Total volume: 3 ml.)
(One (1) lipase unit is the quantity of enzyme which will release fatty acids from a substrate of triolein to require 1 ml. of 0.05 N potassium hydroxide for neutrali zation after a 30-min. incubation period at 37 C.)
(One (1) N.F. unit of tar-chymotrypsin is that quantity of enzyme which will produce an absorbance change of 0.0075/minute at 237 nanometers when incubated with a substrate of N-acetyl-L-tyrosine ethyl ester under the conditions of assay.)
Vial B Glycerol 'kinase: 2 I.U. (International Units) The assay in accordance with the invention is carried out by adding an aliquot of liquid containing the triglyceride to be assayed, which may be for example 50 #1. of serum, to the 3 ml. contents of Vial A. This is then incubated at between 25 C. and 37 C. for approximately ten minutes. The optical density is then determined at 340 nm. Then the 2 I.U. of glycerol kinase contained in Vial B is added, and the mixture allowed to stand for an additional minutes at the same temperature, whereupon the optical density is determined again. The difference is proportional to the triglyceride content of the aliquot.
It may be noted that the essential contents of the reaction mixture in accordance with the invention, especially as packaged for single assays, comprises a microbial lipase; a protease; pyruvate kinase; lactate dehydrogenase; NADH; ATP; Phosphoenol pyruvate; a magnesium ion source; a buffer; and glycerol kinase.
An alternative procedure consists in omitting the NADH and the lactate dehydrogenase from the mixture described above, so that only the first three reaction steps depicted hereinabove occur; and adding a sufiicient quantity of dinitrophenyl hydrazine to react with the pyruvate ion formed in the aforementioned third reaction step. The reaction product is colored when alkalized, and may be readily measured by a colorimeter.
A further alternative procedure is to omit the phosphoenol pyruvate; the pyruvate kinase; and the lactate dehydrogenase from the reaction mixture previously described, and to add instead glycerol phosphate dehydrogenase, whereupon the a-glycerol phosphate and the NAD are converted respectively to dihydroxyacetone phosphate and NADH. The amount of NADH formed, which is proportional to the amount of triglyceride originally present, can conveniently be measured by the increase in fluorescence. An alternative sub-procedure is to include also a sufficient quantity of dinitrophenyl hydrazine in this system as well which will result in the formation of a colored reaction product with the dihydroxyacetone phosphate liberated. The amount of the reaction product can then readily be determined with a colorimeter and is likewise a measure of the triglyceride originally present.
A still further alternative procedure is to utilize a reaction mixture which provides only the enzymatic conversion to glycerol which is the first reaction step set forth in the tabulation hereinabove. The reaction mixture, however, also includes NAD and glycerol dehydrogenase. As a result, the glycerol which is liberated in the first step is converted to dihydroxyacetone with the simultaneous production of NADH. The increase in optical density at 340 nm. then becomes a measure of the quantity of triglyceride originally present, as previously described. A suitable glycerol dehydrogenase is that obtainable from Enterobacter aerogenes; this enzyme is commercially available. An alternative subprocedure here is to add dinitrophenyl hydrazine, which forms a colored reaction product with the dihydroxy acetone, so that the latter may then be measured colorimetrically.
In the two alternative procedures just described, viz, in the first of which glycerol phosphate dehydrogenase and in the second of which glycerol dehydrogenase, respectively, are used, an equivalent amount of NADH is formed, as already mentioned. A further alternative subprocedure applicable to both of these is to utilize the known behavior of variou tetrazolium salts, which upon reduction are converted from colorless, water-soluble compounds to colored dyes. The NADH which is quantitatively formed from the triglyceride may be caused to transfer its hydrogen (becoming oxidized in the process) to the tetrazolium salt, again quantitatively, through the mediation of any of several known substances, among which we prefer especially diaphorase or, alternatively, phenazine methosulfate. The amount of dye thus formed may be readily measured by colorimetry, i.e., by carrying out optical density change measurements in the visible region.
It is not believed necessary to spell out the details of these alternative sub-procedures just described, since they are fully documented in the literature. Representative articles, which together with the literature cited therein are hereby incorporated herein by reference, are the following:
American Journal of Clinical Pathology, vol. 45, No. 5, May, 1966: Rapid Colorimetric (Tetrazolium Salt) Assay for Lactate Dehydrogenase, by R. O. Briere, J. A. Preston, and I. G. Batsakis.
Methods of Enzymatic Analysis, by H. U. Bergmeyer, New York: Academic Press, 1965; pages 953-955.
Coming now to the relative proportions of the selected lipase (or mixture of selected lipases) and the selected protease (or mixture thereof), we prefer that for each 1000 lipase units present in the assay mixture, there be present from about 5 to about 500 international units of protease. We find best a subrange therein of about 20 to about LU. (international units) of protease.
The lipase unit has been defined hereinabove. The international unit of proteolytic activity is the amount of protease which causes a turnover of one micromol per minute of a substrate which is specific for the particular enzyme in question, under conditions approximating an optimum for the system considered. Thus, for cymotrypsin the substrate is tyrosine ethyl ester, and the turnover rate may be determined in any number of ways, as by the change in optical density at 237 nm., or by determining the amino acid liberated, as phenol reagent tyrosine equivalents or by formol titration.
The N.F. (National Formulary) unit is occasionally used for proteases, and appears in an example hereinabove. Since 1 I.U. unit is equivalent to 28 NP. units, it will be seen that the 1100 NR units of chymotrypsin in the example is equal to 39 I.U. Since 1200 lipase units were present in the exemplary mixture, it will be seen that for each 1000 lipase units, our example shows about 32 LU. of protease.
It will be clear from the foregoing that in distributing the components of our preferred assay mixture between Vial A and Vial B, one of the vials, e.g., Vial A, should contain at least the lipase and the protease; whereas the second vial, e.g., Vial B, should contain at least the glycerol kinase. The remaining components may be distributed as desired between the two vials. Our preferred distribution, however, has been set forth hereinabove.
In proceeding in accordance with the invention as has been disclosed hereinabove, it will be found that the glycerol esters are completely hydrolyzed, so that a stoichiometric amount of glycerol is liberated, as indeed has already been explained. We are unable to offer an explanation of the underlying mechanism whereby this is accomplished, but it is clear that it stems from the conjoint presence of the lipase with the protease, all as described and specified. For example, when proceeding in accordance with the detailed example given hereinabove, and when the aqueous medium under test is human serum, it is found that the glycerol liberated is that quantity to be expected on the basis of complete hydrolysis of the triglycerides present, the latter being determined by standard procedures well known in the art.
Those skilled in the art will recognize that a-glycerol phosphate may also be named as glycerol-l-phoshpate; and that the fatty acid glycerol esters in serum may be and generally are referred to simply as triglycerides.
As will be clear from the explanations given hereinabove, one unit of lipase means the amount of lipase equivalent to one lipase unit as specified hereinabove.
We wish it to be understood that we do not desire to be limited to the exact details of components and procedures shown and described, for obvious modifications will occur to a person skilled in the art.
What we claim is:
1. In a process of assaying an aqueous liquid containing a fatty acid glycerol ester for its content of said ester in which said ester is hydrolyzed to liberate all of said glycerol followed by determining the amount of glycerol present, the improvement which consists in effecting said hydrolysis by adding both a lipase and a protease to said liquid, whereby substantially complete hydrolysis of said ester is caused to take place.
2. A process in accordance with claim 1 wherein said lipase is microbial.
3. A process in accordance with claim 2 wherein said lipase is chosen from the class. consisting of Rhizopus delemar and Chromobacferium viscoswm lipases, and mixtures thereof.
4. A process in accordance with claim 3 in which said protease is chosen from the class consisting of chymotrypsin, trypsin, streptomyces griseus protease, elastase, papain, bromelin, and mixtures thereof.
5. A process in accordance with claim 4 wherein from about 5 to about 500 LU. of said protease is present for each 1000 units of said lipase.
6. A process in accordance with claim 2 wherein from about 5 to about 500 LU. of said protease is present for each 1000 units of said lipase.
7. A process in accordance with claim 1 wherein said protease is chosen from the class consisting of chymotrypsin, trypsin, streptomyces griseus protease, elastase, papain, bromelin, and mixtures thereof.
8. A process in accordance with claim 1 wherein from about 5 to about 500 I.U. of said protease is present for each 1000 units of said lipase.
9. A process in accordance with claim 1 wherein said liquid is serum, and said glycerol ester is serum triglyceride.
10. A process in accordance with claim 1 wherein, subsequent to said liberation of glycerol, adenosine triphosphate and glycerol kinase are added to said liquid in sufficient quantity to convert said glycerol to glycerol-l-phosphate and said adenosine triphosphate to adenosine diphosphate; and in which said adenosine diphosphate is assayed, whereby the original content of said fatty acid glycerol ester may be determined..
11. A process in accordance with claim wherein to said aqueous liquid containing said glycerol-l-phosphate, nicotinamide adenine dinucleotide and glycerol phosphate dehydrogenase are added in sufficient quantity to convert said glycerol-l-phosphate and said NAD to dihydroxyacetone phosphate and nicotinamide adenine dinucleotide, reduced (NADH) respectively.
12. The process in accordance with claim 1 wherein said NADH is assayed by fluorimetry.
13. The process in accordance with claim 11 wherein to said aqueous liquid containing said NADH, a tetrazolium salt is added together with a hydrogen transfer agent for said tetrazolium salt, whereby the latter is quantitatively converted to a colored dye with concomitant oxidation of said NADH.
14. The process in accordance with claim 13 wherein said hydrogen transfer agent is selected from the class consisting of diaphorase and phenazine methosulfate.
15. A process in accordance with claim 10 wherein to said aqueous liquid containing said glyceroll-phosphate in said ADP, there are added phosphoenol pyruvate and pyruvate kinase in sufficient quantity to convert said phosphoenol pyruvate to pyruvate ion, and in which said pyruvate ion is assayed to give an indication of the amount of said glycerol ester originally present.
16. A process in accordance with claim 15 wherein said pyruvate is assayed by adding to said aqueous liquid a sufiicient quantity of dinitrophenyl hydrazine to react therewith, whereby a colored compound is formed.
17. A process in accordance with claim 15 wherein to said aqueous liquid containing said pyruvate ion there are added NADH and lactate dehydrogenase in suflicient quantity to convert said pyruvate and said NADH to lactate ion and NAD respectively.
18. The process in accordance with claim 17 in which the concentration of said NAD in said aqueous liquid is determined by measuring the change in optical density thereof at approximately 340 nanometers.
19. The process in accordance with claim 1 wherein, subsequent to said liberation of glycerol, adenosine triphosphate and glycerol kinase are added to said liquid in sufficient quantity to convert said glycerol to glycerol-1- phosphate and said adenosine triphosphate to adenosine diphosphate; and in which said gycerol-l-phosphate is assayed, whereby the original content of said fatty acid glycerol ester may be determined.
20. A process in accordance with claim 19 wherein said glycerol-l-phosphate is assayed by adding to said liquid NAD and glycerol phosphate dehydrogenase, whereby said glycerol-l-phosphate is converted to dihydroxyacetone phosphate and said NAD is converted to NADH; and wherein at least one of said conversion products is assayed to give a measure of the fatty acid glycerol ester originally present.
21. The process in accordance with claim 20 wherein said NADH is measured by determining the increase in fluorescence of said solution.
22. The process in accordance with claim 20 wherein dinitrophenyl hydrazine is added to said liquid, whereby a colored reaction product is formed with said dihydroxyacetone phosphate and wherein the intensity of color produced in said solution is determined as a measure of the dihydroxyacetone phosphate.
23. The process in accordance with claim 1 wherein to said liquid there is added NAD and glycerol dehydrogenase, whereby said glycerol is converted to dihydroxyacetone and said NAD is converted to NADH; and in which said NADH is assayed to give a measure of the fatty acid glycerol ester originally present.
24. The process in accordance with claim 23 wherein to said aqueous liquid containing said NADH, a tetrazolium salt is added together with a hydrogen transfer agent for said tetrazolium salt, whereby the latter is quantitatively converted to a colored dye with concomitant oxidation of said NADH.
25. The process in accordance with claim 24, wherein said hydrogen transfer agent is selected from the class consisting of diaphorase and phenazine methosulfate.
26. The process in accordance with claim 23 wherein said glycerol dehydrogenase is derived from Enterobacteraerogenes.
27. The process in accordance with claim 23 wherein said NADH is assayed by determining the increase in optical density at 340 nm.
28. A reagent combination for the analysis of fatty acid glycerol esters which comprises a first vial containing a lipase and a protease; a second vial containing glycerol kinase; and pyruvate kinase; lactate dehydrogenase; NADH; ATP; phosphoenol pyruvate; a magnesium ion source; and a buffer in any preselected distribution in said vials.
29. A reagent combination in accordance with claim 28 wherein from about 5 to about 500 LU. of said protease is present for each 1000 units of said lipase.
30. A reagent combination in accordance with claim 29 wherein said lipase is a microbial lipase.
31. A reagent combination in accordance with claim 28 wherein said lipase is a microbial lipase.
32. A reagent combination in accordance with claim 28 wherein said lipase is derived from Rhizopus delemar; said protease is a-chymotrypsin; said magnesium ion References Cited UNITED STATES PATENTS 10/1950 Halmbacher 195-3 R OTHER REFERENCES George Guilbault, Enzymatic Methods of Analysis, 1st ed., Pergamon Press, p. 64, 1970.
A. LOUIS MONACELL, Primary Examiner R. J. WARDEN, Assistant Examiner
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9890470A | 1970-12-16 | 1970-12-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
US3703591A true US3703591A (en) | 1972-11-21 |
Family
ID=22271481
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US98904A Expired - Lifetime US3703591A (en) | 1970-12-16 | 1970-12-16 | Triglyceride hydrolysis and assay |
Country Status (17)
Country | Link |
---|---|
US (1) | US3703591A (en) |
JP (2) | JPS549518B1 (en) |
AU (1) | AU475955B2 (en) |
BE (1) | BE776034A (en) |
BR (1) | BR7108185D0 (en) |
CA (1) | CA955161A (en) |
CH (2) | CH563404A5 (en) |
CS (1) | CS212729B2 (en) |
DE (1) | DE2162325C3 (en) |
ES (1) | ES395956A1 (en) |
FR (1) | FR2118454A5 (en) |
GB (1) | GB1373106A (en) |
IL (1) | IL38235A (en) |
IT (1) | IT972079B (en) |
NL (1) | NL180523C (en) |
SE (1) | SE389919B (en) |
ZA (1) | ZA717957B (en) |
Cited By (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS49113695A (en) * | 1973-02-27 | 1974-10-30 | ||
US3862009A (en) * | 1972-06-19 | 1975-01-21 | Boehringer Mannheim Gmbh | Determination of triglycerides |
US3898130A (en) * | 1974-03-18 | 1975-08-05 | American Hospital Supply Corp | Rapid enzymatic hydrolysis of triglycerides |
US3964974A (en) * | 1972-09-28 | 1976-06-22 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Enzymatic determination of glucose |
US4001089A (en) * | 1970-01-21 | 1977-01-04 | The Dow Chemical Company | Method for determination of triglycerides and glycerol |
US4011045A (en) * | 1975-02-14 | 1977-03-08 | Bonderman Dean P | Turbidity reduction in triglyceride standards |
US4012287A (en) * | 1975-11-18 | 1977-03-15 | Dr. Bruno Lange Gmbh | Method and reagent for the quantitative analysis of triglycerides |
US4014744A (en) * | 1975-01-30 | 1977-03-29 | Miles Laboratories Inc. | Processes for measuring tri-, di- and monoglycerides |
US4019961A (en) * | 1974-03-14 | 1977-04-26 | Boehringer Mannheim G.M.B.H. | Analytical enzymatic determination |
US4038146A (en) * | 1974-06-07 | 1977-07-26 | Latron Laboratories, Inc. | Method of determination of serum triglycerides and reagents |
US4045297A (en) * | 1975-12-15 | 1977-08-30 | Monsanto Company | Triglycerides determination method |
US4071413A (en) * | 1975-07-30 | 1978-01-31 | Ono Pharmaceutical Co., Ltd. | Method for determining free fatty acids in blood serum using fatty acid activating enzymes |
DE2737286A1 (en) * | 1976-08-19 | 1978-02-23 | Eastman Kodak Co | MULTI-LAYER ANALYTICAL ELEMENTS FOR DETERMINING TRIGLYCERIDES AND GLYCEROL |
US4142938A (en) * | 1974-03-20 | 1979-03-06 | The Dow Chemical Company | Determination of triglycerides and glycerol |
US4168203A (en) * | 1974-04-30 | 1979-09-18 | Fujisawa Pharmaceutical Co., Ltd. | Quantitative analysis of neutral lipids and lecithin |
US4178285A (en) * | 1978-12-20 | 1979-12-11 | Felts James M | Separation of active α1 -acid glycoprotein and utilization in the lipoprotein lipase enzyme system |
WO1980000260A1 (en) * | 1978-07-13 | 1980-02-21 | American Hospital Supply Corp | Determination of triglycerides and enzyme reagents |
US4195126A (en) * | 1977-10-04 | 1980-03-25 | The Board Of Trustees Of The University Of Alabama | Albumin-dye complex for fatty acid determination |
US4241178A (en) * | 1978-01-06 | 1980-12-23 | Eastman Kodak Company | Process and composition for the quantification of glycerol ATP and triglycerides |
US4245041A (en) * | 1977-12-07 | 1981-01-13 | American Monitor Corporation | Triglycerides assay and reagents therefor |
US4259440A (en) * | 1979-05-21 | 1981-03-31 | Miles Laboratories, Inc. | Hydrolysis and assay of triglycerides |
US4264589A (en) * | 1978-12-20 | 1981-04-28 | Felts James M | Separation of active α1 -acid glycoprotein and utilization in the lipoprotein lipase enzyme system |
US4273870A (en) * | 1978-07-18 | 1981-06-16 | Boehringer Mannheim Gmbh | Method and composition for the determination of glycerol |
US4275152A (en) * | 1977-02-03 | 1981-06-23 | Eastman Kodak Company | Hydrolysis of protein-bound cholesterol esters |
US4275151A (en) * | 1977-02-03 | 1981-06-23 | Eastman Kodak Company | Hydrolysis of protein-bound cholesterol esters |
US4302536A (en) * | 1978-08-15 | 1981-11-24 | Longenecker Robert W | Colorimetric immunoassay process |
US4309502A (en) * | 1980-06-30 | 1982-01-05 | Beckman Instruments, Inc. | Enzymatic assay for glycerol and triglycerides and a reagent for use therein |
EP0044615A2 (en) * | 1980-07-21 | 1982-01-27 | TECHNICON INSTRUMENTS CORPORATION (a New York corporation) | Method for the analysis of triglycerides |
EP0045031A1 (en) * | 1980-07-22 | 1982-02-03 | Baker Instruments Corporation | Glycerol detection reagent and its use |
US4322496A (en) * | 1980-04-17 | 1982-03-30 | Eastman Kodak Company | Inhibition of lactate oxidase |
US4394444A (en) * | 1982-06-21 | 1983-07-19 | Miles Laboratories, Inc. | Cofactor indicator compositions |
US4394445A (en) * | 1979-02-22 | 1983-07-19 | Nix Paul T | Enzymatic glyceride hydrolysis |
US4626511A (en) * | 1985-05-13 | 1986-12-02 | Wayne State University | Composition for reducing turbidity in samples of biological fluids |
US4636465A (en) * | 1983-04-21 | 1987-01-13 | Amano Pharmaceutical Co., Ltd. | Method and composition for determination of glycerol |
US4693971A (en) * | 1983-01-28 | 1987-09-15 | Toyo Jozo Kabushiki Kaisha | Highly sensitive enzyme assay method |
US4923796A (en) * | 1978-08-08 | 1990-05-08 | Boehringer Mannheim Gmbh | Method for the quantitative enzymatic determination of ADP |
US5310679A (en) * | 1985-05-13 | 1994-05-10 | Artiss Joseph D | Composition for reducing turbidity in samples of biological fluids |
EP1329512A1 (en) * | 2000-09-28 | 2003-07-23 | ARKRAY, Inc. | Process for producing protein decomposition product |
US20040137546A1 (en) * | 2002-12-24 | 2004-07-15 | Stepan Company | Method for determination of free and combined glycerin in biodiesel |
US20040157285A1 (en) * | 2001-09-28 | 2004-08-12 | Kaori Ishimaru | Method of storing tetrazolium compound, stabilizer for use therein, and tetrazolium compound reagent solution stored by the method |
US20080299543A1 (en) * | 2007-05-31 | 2008-12-04 | Uti Limited Partnership | Method for Assessing Trace Element Related Disorders in Blood Plasma |
US20110112186A1 (en) * | 2008-02-29 | 2011-05-12 | Isis Innovation Limited | Diagnostic methods |
WO2014066787A1 (en) | 2012-10-26 | 2014-05-01 | Boston Heart Diagnostics Corporation | Diabetes panel |
US9198890B2 (en) | 2011-10-13 | 2015-12-01 | Boston Heart Diagnostics Corporation | Compositions and methods for treating and preventing coronary heart disease |
US9696276B2 (en) | 2008-09-27 | 2017-07-04 | Boston Heart Diagnostics Corporation | Methods for separation and immuno-detection of biomolecules, and apparatus related thereto |
US9739790B2 (en) | 2014-11-17 | 2017-08-22 | Boston Heart Diagnostic Corporation | Cardiovascular disease risk assessment |
US9817001B2 (en) | 2008-05-27 | 2017-11-14 | Boston Heart Diagnostics Corporation | Methods for determining LDL cholesterol treatment |
US9828624B2 (en) | 2013-07-24 | 2017-11-28 | Boston Heart Diagnostics Corporation | Driving patient compliance with therapy |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3884764A (en) * | 1974-03-25 | 1975-05-20 | Eastman Kodak Co | Method and composition for blood serum cholesterol analysis |
CA1056282A (en) * | 1974-03-25 | 1979-06-12 | Charles T. Goodhue | Multilayer analytical elements for use in the assay of cholesterol |
CA1100023A (en) * | 1976-08-19 | 1981-04-28 | Charles T. Goodhue | Process and composition for the quantification of glycerol and triglycerides |
JPS6058746B2 (en) * | 1977-09-22 | 1985-12-21 | 中外製薬株式会社 | Higher fatty acid ester |
-
1970
- 1970-12-16 US US98904A patent/US3703591A/en not_active Expired - Lifetime
-
1971
- 1971-10-13 ES ES295956A patent/ES395956A1/en not_active Expired
- 1971-11-12 FR FR7140669A patent/FR2118454A5/fr not_active Expired
- 1971-11-24 CA CA128,467A patent/CA955161A/en not_active Expired
- 1971-11-26 IL IL38235A patent/IL38235A/en unknown
- 1971-11-26 CH CH202475A patent/CH563404A5/xx not_active IP Right Cessation
- 1971-11-26 ZA ZA717957A patent/ZA717957B/en unknown
- 1971-11-26 CH CH1720671A patent/CH566003A5/xx not_active IP Right Cessation
- 1971-11-30 GB GB5560971A patent/GB1373106A/en not_active Expired
- 1971-11-30 BE BE776034A patent/BE776034A/en not_active IP Right Cessation
- 1971-12-02 AU AU36416/71A patent/AU475955B2/en not_active Expired
- 1971-12-09 BR BR8185/71A patent/BR7108185D0/en unknown
- 1971-12-15 IT IT54760/71A patent/IT972079B/en active
- 1971-12-15 SE SE7116097A patent/SE389919B/en unknown
- 1971-12-15 JP JP10112371A patent/JPS549518B1/ja active Pending
- 1971-12-15 DE DE2162325A patent/DE2162325C3/en not_active Expired
- 1971-12-16 NL NLAANVRAGE7117275,A patent/NL180523C/en not_active IP Right Cessation
- 1971-12-16 CS CS718751A patent/CS212729B2/en unknown
-
1978
- 1978-02-04 JP JP1106278A patent/JPS53114493A/en active Pending
Cited By (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4001089A (en) * | 1970-01-21 | 1977-01-04 | The Dow Chemical Company | Method for determination of triglycerides and glycerol |
US3862009A (en) * | 1972-06-19 | 1975-01-21 | Boehringer Mannheim Gmbh | Determination of triglycerides |
US3964974A (en) * | 1972-09-28 | 1976-06-22 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Enzymatic determination of glucose |
JPS49113695A (en) * | 1973-02-27 | 1974-10-30 | ||
US4019961A (en) * | 1974-03-14 | 1977-04-26 | Boehringer Mannheim G.M.B.H. | Analytical enzymatic determination |
US3898130A (en) * | 1974-03-18 | 1975-08-05 | American Hospital Supply Corp | Rapid enzymatic hydrolysis of triglycerides |
US4142938A (en) * | 1974-03-20 | 1979-03-06 | The Dow Chemical Company | Determination of triglycerides and glycerol |
US4168203A (en) * | 1974-04-30 | 1979-09-18 | Fujisawa Pharmaceutical Co., Ltd. | Quantitative analysis of neutral lipids and lecithin |
US4038146A (en) * | 1974-06-07 | 1977-07-26 | Latron Laboratories, Inc. | Method of determination of serum triglycerides and reagents |
US4014744A (en) * | 1975-01-30 | 1977-03-29 | Miles Laboratories Inc. | Processes for measuring tri-, di- and monoglycerides |
US4011045A (en) * | 1975-02-14 | 1977-03-08 | Bonderman Dean P | Turbidity reduction in triglyceride standards |
US4071413A (en) * | 1975-07-30 | 1978-01-31 | Ono Pharmaceutical Co., Ltd. | Method for determining free fatty acids in blood serum using fatty acid activating enzymes |
US4012287A (en) * | 1975-11-18 | 1977-03-15 | Dr. Bruno Lange Gmbh | Method and reagent for the quantitative analysis of triglycerides |
US4045297A (en) * | 1975-12-15 | 1977-08-30 | Monsanto Company | Triglycerides determination method |
DE2737286A1 (en) * | 1976-08-19 | 1978-02-23 | Eastman Kodak Co | MULTI-LAYER ANALYTICAL ELEMENTS FOR DETERMINING TRIGLYCERIDES AND GLYCEROL |
US4275152A (en) * | 1977-02-03 | 1981-06-23 | Eastman Kodak Company | Hydrolysis of protein-bound cholesterol esters |
US4275151A (en) * | 1977-02-03 | 1981-06-23 | Eastman Kodak Company | Hydrolysis of protein-bound cholesterol esters |
US4195126A (en) * | 1977-10-04 | 1980-03-25 | The Board Of Trustees Of The University Of Alabama | Albumin-dye complex for fatty acid determination |
US4245041A (en) * | 1977-12-07 | 1981-01-13 | American Monitor Corporation | Triglycerides assay and reagents therefor |
US4241178A (en) * | 1978-01-06 | 1980-12-23 | Eastman Kodak Company | Process and composition for the quantification of glycerol ATP and triglycerides |
WO1980000260A1 (en) * | 1978-07-13 | 1980-02-21 | American Hospital Supply Corp | Determination of triglycerides and enzyme reagents |
US4223090A (en) * | 1978-07-13 | 1980-09-16 | American Hospital Supply Corporation | Reagents for the enzymatic determination of triglycerides |
US4273870A (en) * | 1978-07-18 | 1981-06-16 | Boehringer Mannheim Gmbh | Method and composition for the determination of glycerol |
US4923796A (en) * | 1978-08-08 | 1990-05-08 | Boehringer Mannheim Gmbh | Method for the quantitative enzymatic determination of ADP |
US4302536A (en) * | 1978-08-15 | 1981-11-24 | Longenecker Robert W | Colorimetric immunoassay process |
US4178285A (en) * | 1978-12-20 | 1979-12-11 | Felts James M | Separation of active α1 -acid glycoprotein and utilization in the lipoprotein lipase enzyme system |
US4264589A (en) * | 1978-12-20 | 1981-04-28 | Felts James M | Separation of active α1 -acid glycoprotein and utilization in the lipoprotein lipase enzyme system |
US4394445A (en) * | 1979-02-22 | 1983-07-19 | Nix Paul T | Enzymatic glyceride hydrolysis |
US4259440A (en) * | 1979-05-21 | 1981-03-31 | Miles Laboratories, Inc. | Hydrolysis and assay of triglycerides |
US4322496A (en) * | 1980-04-17 | 1982-03-30 | Eastman Kodak Company | Inhibition of lactate oxidase |
US4309502A (en) * | 1980-06-30 | 1982-01-05 | Beckman Instruments, Inc. | Enzymatic assay for glycerol and triglycerides and a reagent for use therein |
EP0044615A3 (en) * | 1980-07-21 | 1982-02-03 | Technicon Instruments Corporation | Method for the analysis of triglycerides |
US4338395A (en) * | 1980-07-21 | 1982-07-06 | Technicon Instruments Corporation | Method for the analysis of triglycerides |
EP0044615A2 (en) * | 1980-07-21 | 1982-01-27 | TECHNICON INSTRUMENTS CORPORATION (a New York corporation) | Method for the analysis of triglycerides |
EP0045031A1 (en) * | 1980-07-22 | 1982-02-03 | Baker Instruments Corporation | Glycerol detection reagent and its use |
US4394444A (en) * | 1982-06-21 | 1983-07-19 | Miles Laboratories, Inc. | Cofactor indicator compositions |
US4693971A (en) * | 1983-01-28 | 1987-09-15 | Toyo Jozo Kabushiki Kaisha | Highly sensitive enzyme assay method |
US4636465A (en) * | 1983-04-21 | 1987-01-13 | Amano Pharmaceutical Co., Ltd. | Method and composition for determination of glycerol |
US5310679A (en) * | 1985-05-13 | 1994-05-10 | Artiss Joseph D | Composition for reducing turbidity in samples of biological fluids |
US4626511A (en) * | 1985-05-13 | 1986-12-02 | Wayne State University | Composition for reducing turbidity in samples of biological fluids |
EP1329512A4 (en) * | 2000-09-28 | 2004-09-01 | Arkray Inc | Process for producing protein decomposition product |
EP1329512A1 (en) * | 2000-09-28 | 2003-07-23 | ARKRAY, Inc. | Process for producing protein decomposition product |
US20030186346A1 (en) * | 2000-09-28 | 2003-10-02 | Masayuki Yagi | Process for producing protein decomposition product |
US8192996B2 (en) | 2001-09-28 | 2012-06-05 | Arkray, Inc. | Method for storing tetrazolium compound, stabilizer used in the same, and tetrazolium compound reagent solution using the method |
US20040157285A1 (en) * | 2001-09-28 | 2004-08-12 | Kaori Ishimaru | Method of storing tetrazolium compound, stabilizer for use therein, and tetrazolium compound reagent solution stored by the method |
US20040137546A1 (en) * | 2002-12-24 | 2004-07-15 | Stepan Company | Method for determination of free and combined glycerin in biodiesel |
US20080299543A1 (en) * | 2007-05-31 | 2008-12-04 | Uti Limited Partnership | Method for Assessing Trace Element Related Disorders in Blood Plasma |
US20110112186A1 (en) * | 2008-02-29 | 2011-05-12 | Isis Innovation Limited | Diagnostic methods |
US9957563B2 (en) | 2008-02-29 | 2018-05-01 | Isis Innovation Limited | Diagnostic methods |
US9817001B2 (en) | 2008-05-27 | 2017-11-14 | Boston Heart Diagnostics Corporation | Methods for determining LDL cholesterol treatment |
US9696276B2 (en) | 2008-09-27 | 2017-07-04 | Boston Heart Diagnostics Corporation | Methods for separation and immuno-detection of biomolecules, and apparatus related thereto |
US9198890B2 (en) | 2011-10-13 | 2015-12-01 | Boston Heart Diagnostics Corporation | Compositions and methods for treating and preventing coronary heart disease |
WO2014066787A1 (en) | 2012-10-26 | 2014-05-01 | Boston Heart Diagnostics Corporation | Diabetes panel |
US9828624B2 (en) | 2013-07-24 | 2017-11-28 | Boston Heart Diagnostics Corporation | Driving patient compliance with therapy |
US9739790B2 (en) | 2014-11-17 | 2017-08-22 | Boston Heart Diagnostic Corporation | Cardiovascular disease risk assessment |
Also Published As
Publication number | Publication date |
---|---|
IL38235A0 (en) | 1972-01-27 |
BR7108185D0 (en) | 1973-05-31 |
IL38235A (en) | 1974-10-22 |
SE389919B (en) | 1976-11-22 |
AU3641671A (en) | 1973-06-07 |
BE776034A (en) | 1972-03-16 |
AU475955B2 (en) | 1976-09-09 |
IT972079B (en) | 1974-05-20 |
NL180523B (en) | 1986-10-01 |
JPS53114493A (en) | 1978-10-05 |
CA955161A (en) | 1974-09-24 |
NL7117275A (en) | 1972-06-20 |
JPS549518B1 (en) | 1979-04-25 |
ES395956A1 (en) | 1974-09-01 |
NL180523C (en) | 1987-03-02 |
ZA717957B (en) | 1972-08-30 |
CS212729B2 (en) | 1982-03-26 |
FR2118454A5 (en) | 1972-07-28 |
DE2162325A1 (en) | 1972-06-22 |
GB1373106A (en) | 1974-11-06 |
CH563404A5 (en) | 1975-06-30 |
DE2162325B2 (en) | 1980-04-24 |
DE2162325C3 (en) | 1980-12-11 |
CH566003A5 (en) | 1975-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3703591A (en) | Triglyceride hydrolysis and assay | |
Shimizu et al. | Enzymatic microdetermination of serum free fatty acids | |
US4242446A (en) | Method for determining a substance in a biological fluid and reagent combination for use in the method | |
CA1125151A (en) | Triglycerides assay and reagents therefor | |
US4259440A (en) | Hydrolysis and assay of triglycerides | |
EP0695363B1 (en) | Detection of biological material | |
US3862009A (en) | Determination of triglycerides | |
US4056442A (en) | Lipase composition for glycerol ester determination | |
US3898130A (en) | Rapid enzymatic hydrolysis of triglycerides | |
GB2026156A (en) | Determination of creatine kinase sub-unit B | |
US4000042A (en) | Diagnostic reagent for the determination of amylase | |
US4338395A (en) | Method for the analysis of triglycerides | |
US4001089A (en) | Method for determination of triglycerides and glycerol | |
US4394445A (en) | Enzymatic glyceride hydrolysis | |
US5962248A (en) | Quantitative determination method for chloride ions | |
KAWADA et al. | Comparative studies on soluble lactonases | |
US4596772A (en) | Reagent for assaying cholinesterase | |
US4206280A (en) | Determination of acid phosphatase | |
Festenstein | Substrates for rumen β-glucosidase | |
US4142938A (en) | Determination of triglycerides and glycerol | |
GB1590736A (en) | Chemical assay method | |
US3838010A (en) | Photometric method for determining lactic acid dehydrogenase or glucose-6-phosphate dehydrogenase | |
Carr et al. | THE EFFECT OF VASODILATORS UPON THE DEPHOSPHORYLATING ENZYMES OF DOGS'CORONARY ARTERIES | |
US4778754A (en) | Reagent for determining the amount of magnesium ions | |
US4349625A (en) | Method for assaying fatty acids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: AMERICAN HOECHST CORPORATION, STATELESS Free format text: MERGER;ASSIGNOR:CALBIOCHEM-BEHRING CORP.;REEL/FRAME:004093/0784 Effective date: 19820916 Owner name: AMERICAN HOECHST CORPORATION Free format text: MERGER;ASSIGNOR:CALBIOCHEM-BEHRING CORP.;REEL/FRAME:004093/0784 Effective date: 19820916 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED FILE - (OLD CASE ADDED FOR FILE TRACKING PURPOSES) |